octanate 100 i.e./ml pulver und lösungsmittel zur herstellung einer injektionslösung
octapharma pharmazeutika produktionsges.m.b.h - gerinnungsfaktor viii - gerinnungsfaktor viii
octanate 50 i.e./ml pulver und lösungsmittel zur herstellung einer injektionslösung
octapharma pharmazeutika produktionsges.m.b.h - gerinnungsfaktor viii - gerinnungsfaktor viii
albumin (human)- albumin human solution
octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 200 g in 1000 ml - albumin (human) 20% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 20% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 20% will be temporary unless the underlying disorder is reversed. albumin (human) 20% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui
albumin (human)- albumin human solution
octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 250 g in 1000 ml - albumin (human) 25% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 25% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 25% will be temporary unless the underlying disorder is reversed. albumin (human) 25% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui
humanalbumin 20% octapharma
octapharma gmbh (3237398) - plasmaproteine vom menschen mit mindestens 95% albumin - infusionslösung - teil 1 - infusionslösung; plasmaproteine vom menschen mit mindestens 95% albumin (08281) 200 gramm
humanalbumin 5% octapharma
octapharma gmbh (3237398) - plasmaproteine vom menschen mit mindestens 95% albumin - infusionslösung - teil 1 - infusionslösung; plasmaproteine vom menschen mit mindestens 95% albumin (08281) 50 gramm
albunorm 200g/l
octapharma pharmazeutika produktionsges m.b.h., - austria - albuminum umane - sol. perf. - 200g/l - sange si substituenti de sange substituenti de sange si fractiuni proteice plasmatice
albunorm 250 g/l
octapharma pharmazeutika produktionsges m.b.h., - austria - albuminum umane - sol. perf. - 250g/l - sange si substituenti de sange substituenti de sange si fractiuni proteice plasmatice
albunorm 50g/l
octapharma pharmazeutika produktionsges m.b.h., - austria - albuminum umane - sol. perf. - 50g/l - sange si substituenti de sange substituenti de sange si fractiuni proteice plasmatice
octagam 10 % 100 mg/ml soluţie perfuzabilă
octapharma pharmazeutika produktionsges. m.b.h - immunoglobulinum umane - soluţie perfuzabilă - 100 mg/ml